Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Starbucks
SBUX
|
+$382M |
| 2 |
CELG
Celgene Corp
CELG
|
+$329M |
| 3 |
Tesla
TSLA
|
+$261M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$254M |
| 5 |
Intel
INTC
|
+$246M |
Top Sells
| 1 |
Fortive
FTV
|
+$1.15B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$331M |
| 5 |
Amazon
AMZN
|
+$262M |
Sector Composition
| 1 | Technology | 13.89% |
| 2 | Healthcare | 13.88% |
| 3 | Financials | 13.32% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Corbus Pharmaceuticals
CRBP
$116M
| $761K | ﹤0.01% |
4,342
+3,336
| +332% | +$585K |
|
|
UCFC
2377
DELISTED
United Community Financial Corp
UCFC
| $761K | ﹤0.01% |
85,996
-34,431
| -29% | -$305K |
|
|
KRA
2378
DELISTED
Kraton Corporation
KRA
| $757K | ﹤0.01% |
34,673
-49,583
| -59% | -$1.08M |
|
|
DCOM
2379
DELISTED
Dime Community Bancshares
DCOM
| $752K | ﹤0.01% |
44,282
+25,285
| +133% | +$429K |
|
2380
Monro
MNRO
$519M
| $749K | ﹤0.01% |
10,901
-6,408
| -37% | -$440K |
|
2381
iShares Russell Mid-Cap Value ETF
IWS
$14.2B
| $743K | ﹤0.01% |
+9,738
| New | +$743K |
|
2382
Mesa Laboratories
MLAB
$339M
| $743K | ﹤0.01% |
3,566
-26,586
| -88% | -$5.54M |
|
|
MYOV
2383
DELISTED
Myovant Sciences Ltd.
MYOV
| $743K | ﹤0.01% |
45,274
-355,089
| -89% | -$5.83M |
|
2384
Ducommun
DCO
$1.39B
| $741K | ﹤0.01% |
20,397
+11,398
| +127% | +$414K |
|
2385
MasTec
MTZ
$15B
| $738K | ﹤0.01% |
18,200
-401,610
| -96% | -$16.3M |
|
2386
Manulife Financial
MFC
$54.2B
| $737K | ﹤0.01% |
51,953
-165,754
| -76% | -$2.35M |
|
2387
Geron
GERN
$810M
| $736K | ﹤0.01% |
+736,307
| New | +$736K |
|
|
JNCE
2388
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $735K | ﹤0.01% |
218,024
-422,237
| -66% | -$1.42M |
|
|
UPL
2389
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $735K | ﹤0.01% |
966,466
+346,450
| +56% | +$263K |
|
|
CBMB
2390
DELISTED
CBM Bancorp, Inc.
CBMB
| $734K | ﹤0.01% |
+58,639
| New | +$734K |
|
|
ALX
2391
Alexander's
ALX
$1.25B
| $732K | ﹤0.01% |
2,401
-4,228
| -64% | -$1.29M |
|
|
OPOF
2392
DELISTED
Old Point Financial
OPOF
| $731K | ﹤0.01% |
33,505
-4,379
| -12% | -$95.5K |
|
2393
Prothena Corp
PRTA
$442M
| $731K | ﹤0.01% |
70,962
-667,063
| -90% | -$6.87M |
|
|
SBBP
2394
DELISTED
Strongbridge Biopharma plc.
SBBP
| $730K | ﹤0.01% |
162,985
-474,721
| -74% | -$2.13M |
|
2395
Energy Recovery
ERII
$764M
| $729K | ﹤0.01% |
108,269
-134,514
| -55% | -$906K |
|
|
IPHI
2396
DELISTED
INPHI CORPORATION
IPHI
| $729K | ﹤0.01% |
+22,674
| New | +$729K |
|
2397
CryoPort
CYRX
$433M
| $727K | ﹤0.01% |
65,941
-198,829
| -75% | -$2.19M |
|
2398
IDT Corp
IDT
$1.67B
| $727K | ﹤0.01% |
117,457
-212,600
| -64% | -$1.32M |
|
|
FSP
2399
Franklin Street Properties
FSP
$174M
| $724K | ﹤0.01% |
116,135
+86,858
| +297% | +$541K |
|
2400
Liberty Global Class C
LBTYK
$4.07B
| $724K | ﹤0.01% |
35,093
-71,373
| -67% | -$1.47M |
|